Brain Responses to Visceral and Somatic Stimuli in Patients With Irritable Bowel Syndrome With and Without Fibromyalgia

University of Pittsburgh, Pittsburgh, Pennsylvania, United States
The American Journal of Gastroenterology (Impact Factor: 10.76). 06/2003; 98(6):1354-61. DOI: 10.1111/j.1572-0241.2003.07478.x
Source: PubMed


Symptoms of irritable bowel syndrome (IBS) and fibromyalgia (FM) commonly coexist. We hypothesized that one of the mechanisms underlying this comorbidity is increased activation of brain regions concerned with the processing and modulation of visceral and somatic afferent information, in particular subregions of the anterior cingulate cortex (ACC).
Regional cerebral blood flow (rCBF) was assessed in age-matched female IBS (n = 10) and IBS + FM (n = 10) subjects using H(2)(15)O positron emission tomography during noxious visceral (rectal) and somatic pressure stimuli.
GI symptom severity was significantly higher in the IBS patients compared with the IBS + FM patients (p < 0.05). In addition, IBS + FM patients rated somatic pain as more intense than their abdominal pain (p < 0.05). Whereas the somatic stimulus was less unpleasant than the visceral stimulus for IBS patients without FM, the somatic and visceral stimuli were equally unpleasant in the IBS + FM group. Group differences in regional brain activation were entirely within the middle subregion of the ACC. There was a greater rCBF increase in response to noxious visceral stimuli in IBS patients and to somatic stimuli in IBS + FM patients.
Chronic stimulus-specific enhancement of ACC responses to sensory stimuli in both syndromes may be associated with cognitive enhancement of either visceral (IBS) or somatic (IBS + FM) sensory input and may play a key pathophysiologic role in these chronic pain syndromes.

Download full-text


Available from: Stuart W G Derbyshire
  • Source
    • "In addition, the reporting of chronic pain may result from aberrant sensory processing within the CNS. Aberrant sensory processing is understood to be the underlying pain mechanism for those with FGID and fibromyalgia (Chang et al, 2003). It is also suggested that sympathetic overactivity contributes to central modulation, thus enhancing maladaptive behaviour "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Joint Hypermobility Syndrome (JHS) is a multisystemic connective tissue disorder characterised by pain, tissue fragility and laxity. This study aims to investigate the prevalence of chronic widespread pain (CWP) and the extended neurophysiological features reported by a group of patients with JHS. Methods: Ninety patients with JHS (mean age 34.7 ± 9.9 years), which was diagnosed in accordance with the Brighton criteria, and 113 healthy volunteers (mean age 35.7 ± 12.9) with no musculoskeletal pain participated in the study. A self-report questionnaire and pain chart were employed to collect data. Results: CWP was reported by 86% of patients with JHS. The mean number of pain sites in this group was 9.8/17 ± 4.2. Fibromyalgia was reported by 19% of this group. Patients with JHS were significantly more likely to report the following than healthy volunteers: autonomic symptoms (70%, 12%); gastrointestinal symptoms (71%, 9%); and chronic fatigue syndrome (31%, 1%). Patients with JHS reported significantly higher mean functional difficulties scores (22.28 ± 4.90) than healthy volunteers (17.96 ± 3.73) (P<0.001), indicative of functional difficulties associated with developmental coordination disorder/dyspraxia. Conclusion: Patients with JHS reported a wide range of neurophysiological symptoms of which CWP was a salient feature. There is a need to acknowledge and understand the extended symptoms associated with CWP in order to address the holistic needs of patients with JHS. Further studies and discussion are required to identify the complex inter-related multifactorial neurophysiological mechanisms in those with JHS.
    Full-text · Article · Feb 2014 · International Journal of Therapy and Rehabilitation
  • Source
    • "Likewise, pain in TMD patients was greater in women compared to men (Schmid-Schwap et al., 2013). These conditions involve different peripheral organs but symptoms may coexist in the same patient (Aaron et al., 2000; Chang et al., 2003a; Kurland et al., 2006; Tietjen et al., 2010; Veale et al., 1991). Although genetic predisposition and previous psychological or physical (e.g., inflammation ) challenges may contribute to the occurrence of deep tissue pain, in many cases no obvious pathophysiological signs in the peripheral tissue/nerve could be detected at the time of medical evaluation, pointing to dysregulation of central nervous system function as a potential cause of excessive pain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Women disproportionately suffer from many deep tissue pain conditions. Experimental studies show that women have lower pain thresholds, higher pain ratings and less tolerance to a range of painful stimuli. Most clinical and epidemiological reports suggest female gonadal hormones modulate pain for some, but not all, conditions. Similarly, animal studies support greater nociceptive sensitivity in females in many deep tissue pain models. Gonadal hormones modulate responses in primary afferents, dorsal horn neurons and supraspinal sites, but the direction of modulation is variable. This review will examine sex differences in deep tissue pain in humans and animals focusing on the role of gonadal hormones (mainly estradiol) as an underlying component of the modulation of pain sensitivity.
    Full-text · Article · Jul 2013 · Frontiers in Neuroendocrinology
  • Source
    • "FMS is considered a disorder of somatic hypersensitivity, while IBS is considered a disorder of visceral hypersensitivity. Although IBS patients have been reported to have lower, rather than higher thresholds for somatic stimulation,11,12 Chang et al.31 reported that female IBS patients with co-morbid FMS have increased sensitivity to somatic stimuli, while those with IBS without FMS show a blunted response. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The irritable bowel syndrome (IBS) is the best known of the functional gastrointestinal tract disorders. Many IBS patients have at least one co-morbid somatic complaint and many meet diagnostic criteria for other functional disorders. Patients with IBS and another functional disorder, in comparison with patients with IBS only, have more severe IBS symptoms, a higher rate of psychopathology, greater impairment of quality of life, and more illness-related work absenteeism. Estimates of the prevalence of IBS in patients with fibromyalgia range from 30-35% to as high as 70%. Studies of IBS among patients with chronic fatigue syndrome have reported a prevalence ranging from 35-92%. The prevalence of IBS among patients with chronic fatigue syndrome is reported to be 14%. IBS patients with other co-morbid functional disorders appear to manifest a greater degree of somatization. It has been suggested that the presence of multiple co-morbid disorders may be a marker for psychological influences on etiology. This raises the question of whether the functional syndromes represent the same pathophysiological process, i.e., are the same entity that has been separated into different clinical entities because of medical sub-specialization, or are indeed separate disorders. While the answer to this question awaits further research, it would appear that most functional patients who meet formal diagnostic criteria for more than one functional disorder manifest one disorder clinically more that the others and seek consultation differentially for that set of symptoms.
    Full-text · Article · Apr 2010 · Journal of neurogastroenterology and motility
Show more